Catalyst Wire Dossier Catalyst Wire Dossier

Gilotrif

Afatinib · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

43 regulatory and trial events tracked for Gilotrif, covering 2009-08-21 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck [Phase 2]

See pricing